Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Takeuchi, S. Nicole, A. Misaki, M. Furihata, J. Iwata, H. Sonobe, Y. Ohtsuki (2001)
Expression of SMARCF1, a truncated form of SWI1, in neuroblastoma.The American journal of pathology, 158 2
J. Massano, F. Regateiro, G. Januário, Artur Ferreira (2006)
Oral squamous cell carcinoma: review of prognostic and predictive factors.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 102 1
Bin Guan, Tian-Li Wang, I. Shih (2011)
ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.Cancer research, 71 21
Kimberly Wiegand, Anna Lee, Osama Al-Agha, C. Chow, S. Kalloger, D. Scott, C. Steidl, S. Wiseman, R. Gascoyne, B. Gilks, D. Huntsman (2011)
Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomasThe Journal of Pathology, 224
B. Wilson, C. Roberts (2011)
SWI/SNF nucleosome remodellers and cancerNature Reviews Cancer, 11
R. Cassidy, J. Switchenko, N. Jegadeesh, M. Sayan, M. Ferris, B. Eaton, K. Higgins, J. Wadsworth, K. Magliocca, N. Saba, J. Beitler (2017)
Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue CancersJAMA Otolaryngology–Head & Neck Surgery, 143
Xianyu Zhang, Qian Sun, M. Shan, M. Niu, Tong Liu, Bingshu Xia, Xiaoshuan Liang, Wei Wei, Shan-shan Sun, You-xue Zhang, Xiaolong Liu, Qingbin Song, Yan-mei Yang, Yuyan Ma, Yang Liu, Long Yang, Yanlv Ren, Guoqiang Zhang, D. Pang (2013)
Promoter Hypermethylation of ARID1A Gene Is Responsible for Its Low mRNA Expression in Many Invasive Breast CancersPLoS ONE, 8
G. Ciriello, Martin Miller, B. Aksoy, Y. Şenbabaoğlu, N. Schultz, C. Sander (2013)
Emerging landscape of oncogenic signatures across human cancersNature genetics, 45
Zhang Tao, J. Lubek, A. Salama, D. Dyalram, Xinggang Liu, R. Ord (2014)
Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters.Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 72 2
T. Takeuchi, A. Misaki, S. Liang, A. Tachibana, Nakanobu Hayashi, H. Sonobe, Y. Ohtsuki (2000)
Expression of T‐Cadherin (CDH13, H‐Cadherin) in Human Brain and Its Characteristics as a Negative Growth Regulator of Epidermal Growth Factor in Neuroblastoma CellsJournal of Neurochemistry, 74
Chika Takao, Akemi Morikawa, Hiroshi Ohkubo, Yusuke Kito, Chiemi Saigo, Takuji Sakuratani, M. Futamura, T. Takeuchi, Kazuhiro Yoshida (2017)
Downregulation of ARID1A, a component of the SWI/SNF chromatin remodeling complex, in breast cancerJournal of Cancer, 8
Wen-Cheng Lu, Chung-Ji Liu, H. Tu, Y. Chung, Cheng-Chieh Yang, S. Kao, Kuo-Wei Chang, Shu-Chun Lin (2016)
miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinomaOncotarget, 7
C. Kandoth, M. McLellan, Fabio Vandin, K. Ye, B. Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua McMichael, Matthew Wyczalkowski, Mark Leiserson, Christopher Miller, J. Welch, M. Walter, M. Wendl, T. Ley, R. Wilson, Benjamin Raphael, L. Ding (2013)
Mutational landscape and significance across 12 major cancer typesNature, 502
Siân Jones, Tian-Li Wang, I. Shih, T. Mao, K. Nakayama, R. Roden, Ruth Glas, D. Slamon, L. Diaz, B. Vogelstein, K. Kinzler, V. Velculescu, N. Papadopoulos (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 330
Purpose This study aimed to investigate the relationship between loss of AT-rich interactive domain-containing protein 1A (ARID1A) expression and the prognosis of patients with oral squamous cell carcinoma (OSCC). Methods Seventy-five OSCC tissue specimens were immunohistochemically stained with a specific antibody to ARID1A. The immunoreactivity of ARID1A was then correlated with clinicopathological factors, including the prognosis of the patients. Results Non-tumorous oral squamous cells exhibited nuclear ARID1A staining, whereas the invasive OSCC cells showed different degrees of loss of ARID1A immunoreactivity. Little-to-no ARID1A immunoreactivity was found at the cancer inva - sion front in 20 of the 75 OSCC tissue specimens, with significant association with unfavorable patient outcomes. Notably, downregulation of ARID1A immunoreactivity was also related to lymphovascular involvement and poor outcome in patients with T1 and T2 OSCC without lymph node metastasis. Conclusions The results suggest that loss of ARID1A expression at the cancer invasion front might be related to tumor progression in many OSCCs. Keywords Oral squamous cell carcinoma · ARID1A · Chromatin remodeling complex · Outcome Introduction therapies, it is important to unravel the molecular pathways of OSCC progression. The incidence of oral squamous cell carcinoma (OSCC) AT-rich interactive domain-containing protein 1A has increased in recent years [1], and
Oral Cancer – Springer Journals
Published: Jan 19, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.